Comparison of dynamic contour tonometry with Goldmann applanation tonometry

Department of Ophthalmology, University of Zurich, Switzerland.
Investigative Ophthalmology &amp Visual Science (Impact Factor: 3.66). 10/2004; 45(9):3118-21. DOI: 10.1167/iovs.04-0018
Source: PubMed

ABSTRACT The dynamic contour tonometer (DCT; Pascal tonometer) is a novel tonometer designed to measure intraocular pressure (IOP) independent of corneal properties. The purpose of this study was a comparison of the DCT with the Goldmann applanation tonometer (GAT) with respect to mean of IOP readings, the influence of ocular structural factors on IOP readings, and both intra- and interobserver variability, in a large group of healthy subjects.
In a prospective study of 228 eyes, IOP measurements by GAT and DCT were compared, and the effects of central corneal thickness (CCT), corneal curvature, axial length, and anterior chamber depth were analyzed. To evaluate intra- and interobserver variability, IOP was measured in eight eyes by four observers.
There was a high concordance between the IOP readings obtained by DCT and GAT. However, IOP readings were consistently higher with DCT than with GAT (median difference: +1.7 mm Hg, interquartile range [25th-75th percentile] = 0.8-2.7 mm Hg). In contrast to GAT, multivariable regression analysis showed no significant effect of corneal thickness, corneal curvature, astigmatism, anterior chamber depth, and axial length on DCT readings. For repeated measurements the intraobserver variability was 0.65 mm Hg for the DCT and 1.1 mm Hg for the GAT (P = 0.008). Interobserver variability was 0.44 mm Hg for the DCT and 1.28 mm Hg for the GAT (P = 0.017).
IOP measurements by DCT are highly concordant with IOP readings obtained from GAT but do not vary in CCT and have a lower intra- and interobserver variability. DCT seems to be an appropriate method of tonometry for routine clinical use.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: The aim was to ascertain if any differences exist in diurnal central corneal thickness (CCT) and intra-ocular pressure (IOP) between eyes with pseudoexfoliation (PXF) syndrome without glaucoma and eyes with no ocular pathology. A secondary aim was to determine whether there was a significant relationship between CCT and IOP. Settings and Design: This study was a prospective design conducted within a hospital setting. Materials and Methods: The experimental group consisted of seven participants with bilateral PXF (14 eyes) and the control group comprised of 15 participants (30 eyes). Testing included CCT and IOP measured at four different times on one given day (8.00 a.m.; 11 a.m.; 2 p.m. and 5 p.m.). Statistical Analysis: The data were analyzed with the generalized linear latent mixed model. Results: PXF eyes displayed a significantly thinner overall mean CCT (520 μm) compared to controls (530 μm). Furthermore, a significant reduction in CCT and IOP occurred in the PXF group from 8 a.m. to 5 p.m. The mean overall IOP in PXF eyes was significantly lower than the control group. A significant association between IOP and CCT was also found in PXF eyes. Conclusions: Displaying a significantly thinner mean CCT highlights the importance of measuring CCT in an ophthalmic clinical setting as to avoid falsely underestimated IOP measurements in such a high-risk glaucoma population. Furthermore, a statistically significant correlation between IOP and CCT in PXF eyes suggests that the reduction in CCT that occurred in PXF eyes between 8 a.m. and 5 p.m. may be partly responsible for the reduction in IOP measurements.
    Indian Journal of Ophthalmology 12/2014; 62:1072-6. DOI:10.4103/0301-4738.146755 · 0.93 Impact Factor
  • Source
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Justificativa e objetivos: A anestesia peribulbar pode reduzir o fluxo sanguíneo ocular (FSO) por elevação da pressão intraocular (PIO) ou ação de fármacos. A ropivacaína tem baixa toxicidade e ação vasoconstritora intrínseca ainda não comprovada sobre vasculatura ocular. Medidas da amplitude de pulso ocular (APO) permitem avaliação indireta do FSO. O objetivo deste estudo é avaliar, via FSO, a ação vasoconstritora da ropivacaína em anestesia peribulbar. Método: Quarenta olhos submetidos a bloqueio peribulbar com 7 mL de solução anestésica, sem vasoconstritor, foram separados aleatoria-mente em dois grupos: ropivacaína (n = 20) e bupivacaína (n = 20). Foram avaliados PIO, pressão de perfusão ocular (PPO), APO, variáveis hemodinâmicas e grau de acinesia antes e aos 5 e 10 minutos após bloqueio peribulbar. Para avaliação dos parâmetros oculares, utilizou-se tonômetro de contorno dinâmico. A sedação foi idêntica nos dois grupos. Resultados: Não houve variação significativa dos parâmetros hemodinâmicos e da intensidade de bloqueio motor entre os grupos. Aos 5 e 10 minutos houve diferença de PIO, PPO e APO entre os grupos (p < 0,05). A variação da PIO aos 5 e 10 minutos foi, respectivamente, de -0,88% e -4,54% com ropivacaína e 17,61% e 16,56% com bupivacaína. A alteração da PPO após 5 e 10 minutos foi de 1,5% e 4,2% com ropivacaína, e de -7% e -6% com bupivacaína. A APO variou -55,59% e -59,67% com ropivacaína aos 5 e 10 minutos, e -34,71% e -28,82% com bupivacaína.
    Revista Brasileira de Anestesiologia 01/2010; 60(5). DOI:10.1590/S0034-70942010000500006 · 0.42 Impact Factor

Full-text (2 Sources)

Available from
Nov 26, 2014